HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

TAK 637

structure in first source
Also Known As:
(aR,9R)-7-(3,5-bis(trifluoromethyl)benzyl)-8,9,10,11-tetrahydro-9-methyl-5-(4-methylphenyl)-7H-(1,4)diazocino(2 1-g)(1,7)naphthyridine-6,13-dione; TAK-637; TAK637
Networked: 4 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Johnson, Anthony C: 1 article (03/2003)
2. Venkova, Kalina: 1 article (03/2003)
3. Sutkowski-Markmann, Debra: 1 article (03/2003)
4. Gibson, Matthew S: 1 article (03/2003)
5. Greenwood-Van Meerveld, Beverley: 1 article (03/2003)
6. Inatomi, Nobuhiro: 1 article (03/2002)
7. Ikeura, Yoshinori: 1 article (03/2002)
8. Okano, Shiho: 1 article (03/2002)
9. Furness, J B: 1 article (10/2001)
10. Ikeura, Y: 1 article (08/2001)

Related Diseases

1. Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
2. Pain (Aches)
3. Urinary Incontinence
4. Hypersensitivity (Allergy)

Related Drugs and Biologics

1. Tachykinins
2. 3- (2- methoxybenzylamino)- 2- phenylpiperidine
3. Neurokinin-1 Receptors (Neurokinin 1 Receptor)

Related Therapies and Procedures

1. Oral Administration